|
⚲
|
| Keyboard |
| Christopher Starr | |
|---|---|
| Firm | |
| Address | 4 King Street West, Suite 401 Toronto, A6 M5H 1B6 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Thiogenesis Therapeutics Corp | 021-554081 | Director | 0.1 M of 0.1 M |
||
| Thiogenesis Therapeutics Corp | 021-500297 | Director | 0.3 M of 0.3 M |
||
| Thiogenesis Therapeutics Corp | 021-465814 | Director | 0.2 M of 0.2 M |
||
| Raptor Recycle & Transfer LLC | 021-404871 | Director | 2.3 M of 2.3 M |
||
| Monopar Therapeutics | 021-293312 | Executive Officer | of 4.5 M |
||
| Monopar Therapeutics | 021-283447 | Executive Officer | of 10.0 M |
||
| Glycomine Inc | 021-274291 | Director | 4.9 M of 12.6 M |
||
| Monopar Therapeutics | 021-259272 | Executive Officer | of 3.0 M |
||
| Monopar Therapeutics | 021-242087 | Executive Officer | 2.1 M of 6.0 M |
||
| Raptor Pharmaceutical Corp | 021-146606 | Executive Officer | 15.1 M of 15.1 M |
||
| Raptor Pharmaceuticals Corp | 021-120712 | Executive Officer | 2.4 M of 2.4 M |
||
| Mid-Atlantic Angel Group II LP | 021-130406 | Executive Officer | 4.6 M of 10.0 M |
||